| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,142 | +7.14% | |
| 1 year | ₹60,000 | ₹63,986 | +6.64% | |
| 3 years | ₹1,80,000 | ₹2,21,592 | +23.11% | |
| 5 years | ₹3,00,000 | ₹4,31,085 | +43.70% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.69% |
| Divi's Laboratories Ltd | Healthcare | Equity | 9.47% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.89% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 6.62% |
| Neuland Laboratories Ltd | Healthcare | Equity | 5.57% |
| Navin Fluorine International Ltd | Materials | Equity | 5.20% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.02% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 4.90% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 4.67% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.16% |
| Gland Pharma Ltd | Healthcare | Equity | 3.60% |
| Global Health Ltd | Healthcare | Equity | 3.20% |
| Repo | Unspecified | Repo | 3.17% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.12% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.97% |
| Artemis Medicare Services Ltd | Healthcare | Equity | 2.86% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 2.84% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 2.82% |
| Biocon Ltd | Healthcare | Equity | 2.77% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 2.74% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 2.49% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 2.37% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 1.94% |
| Net Payables | Unspecified | Net Payables | -0.10% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +16.2% | +21.7% | +12.2% | +17.8% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 16 | 8 | 11 | -- |